Vanguard Personalized Indexing Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Buy
13,929
+2,171
+18% +$31K ﹤0.01% 1966
2026
Q1
$197K Sell
11,758
-124
-1% -$2.22K ﹤0.01% 1835
2025
Q4
$190K Sell
11,882
-1,190
-9% -$17.7K ﹤0.01% 1731
2025
Q3
$162K Buy
13,072
+388
+3% +$4.55K ﹤0.01% 1750
2025
Q2
$146K Buy
+12,684
New +$150K ﹤0.01% 1683
2025
Q1
Sell
-13,591
Closed -$235K 1857
2024
Q4
$235K Sell
13,591
-250
-2% -$4.82K ﹤0.01% 1450
2024
Q3
$256K Sell
13,841
-66
-0.5% -$1.32K ﹤0.01% 1418
2024
Q2
$282K Buy
13,907
+1,907
+16% +$33.7K 0.01% 1296
2024
Q1
$205K Buy
+12,000
New +$189K ﹤0.01% 1431

Other funds holding CLB

Vanguard Personalized Indexing Management's CLB Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Core Laboratories (CLB) stake by 18% in Q2 2026, buying an estimated $31K and bringing the position to 13,929 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

Vanguard Personalized Indexing Management first reported a position in CLB in Q1 2024 and has held it in 9 quarters since. The position peaked at $282K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Vanguard Personalized Indexing Management held 13,929 shares of Core Laboratories worth $162K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 2,171 Core Laboratories shares in Q2 2026, an estimated $31K.
  • Core Laboratories made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1966 holding.
  • Vanguard Personalized Indexing Management first reported a position in Core Laboratories in Q1 2024 and has held it in 9 quarters since.
  • Vanguard Personalized Indexing Management's Core Laboratories position peaked at $282K in Q2 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.